$0.753
+0.003 (+0.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RNTX por análisis de gráficos similares
Alphio's RNTX stock price prediction model matches the current Rein Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.75 (-0.87%). The 1-week path is $0.75 (+0.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Rein Therapeutics Inc?
Rein Therapeutics, Inc. is currently not a strong buy due to its recent performance and financial metrics. The stock closed at $0.76, down 39.03% year-to-date and 43.55% over the past year, indicating significant volatility and investor concern. The RSI is at 33.698, suggesting the stock is oversold, but the negative trend in net income, which showed a loss of $63.75 million in Q2 2026, raises caution. The main risk is the company's high debt-to-equity ratio of 42.47% in Q1 2026, which could impact financial stability.
RNTX cerró en $0.75 el Tuesday, tras subir +0.37%
Rein Therapeutics Inc (RNTX) last closed at $0.7527, gaining +0.37%. These facts feed the 1-day and 1-week RNTX price prediction above.
Factores de la previsión
Los factores de la previsión de Rein Therapeutics Inc (RNTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RNTX, ordenadas por similitud.
Análisis de estacionalidad de RNTX
Historically the probability of a positive September return for RNTX is 16.67%. April offers the highest probability of a positive month at 64.06%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RNTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.43 | $1.71 | $1.82 | +127.80% |
| Oct 2026 | $1.60 | $1.65 | $1.90 | +118.75% |
| Nov 2026 | $1.15 | $1.27 | $1.41 | +68.42% |
| Dec 2026 | $1.16 | $1.49 | $1.71 | +97.76% |
En 2026, se proyecta que Rein Therapeutics Inc (RNTX) oscile entre $1.15 y $1.90.
Previsión mensual de Rein Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Rein Therapeutics Inc promedie $1.71, con un mínimo de $1.43 y un máximo de $1.82.
En Oct de 2026, se proyecta que Rein Therapeutics Inc promedie $1.65, con un mínimo de $1.60 y un máximo de $1.90.
En Nov de 2026, se proyecta que Rein Therapeutics Inc promedie $1.27, con un mínimo de $1.15 y un máximo de $1.41.
En Dec de 2026, se proyecta que Rein Therapeutics Inc promedie $1.49, con un mínimo de $1.16 y un máximo de $1.71.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.